← Back to Search

TIDE Project: Biomarker Discovery for Chronic Tinnitus Diagnosis (TIDE Trial)

N/A
Recruiting
Led By Sven Vanneste, Prof.
Research Sponsored by University of Regensburg
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 hours
Awards & highlights
No Placebo-Only Group

Summary

Research in clinical neuroscience is founded on the conviction that a better understanding of tinnitus related changes of brain function will improve our ability to diagnose and treat tinnitus. Although considerable advances have been made in understanding the mechanisms of tinnitus, the clinical management of tinnitus remains largely based on a 'trial and error' approach. The identification and validation of a biomarker for tinnitus is thought to be the crucial step in the development of a personalized approach to the diagnosis and treatment of tinnitus. The overarching goal of this study is to incorporate advanced technologies to provide an objective, data-driven, personalized approach to the diagnosis of chronic tinnitus. This should lead to a clinically applicable tool that can be widely and easily used.

Eligible Conditions
  • Tinnitus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Event-related potentials

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Tinnitus cases/patientsExperimental Treatment1 Intervention
Subjects that have a diagnosis of chronic and constant tinnitus (for at least 6 months based on history)
Group II: Control groupExperimental Treatment1 Intervention
Subjects that never experienced tinnitus (excluding short-term tinnitus, i.e. not tinnitus that persists over a longer period of time)

Find a Location

Who is running the clinical trial?

University of Dublin, Trinity CollegeOTHER
115 Previous Clinical Trials
35,629 Total Patients Enrolled
Brai3n - Brain Research Center for Advanced, Innovative, Interdisciplinary and International NeuromodulationUNKNOWN
University of Texas at AustinOTHER
378 Previous Clinical Trials
86,049 Total Patients Enrolled
Eastern Switzerland University of Applied SciencesOTHER
4 Previous Clinical Trials
133 Total Patients Enrolled
Universität TübingenOTHER
28 Previous Clinical Trials
11,084 Total Patients Enrolled
University of RegensburgLead Sponsor
91 Previous Clinical Trials
35,773 Total Patients Enrolled
15 Trials studying Tinnitus
12,372 Patients Enrolled for Tinnitus
University Hospital, ZürichOTHER
82 Previous Clinical Trials
626,016 Total Patients Enrolled
University of Illinois at Urbana-ChampaignOTHER
199 Previous Clinical Trials
39,905 Total Patients Enrolled
1 Trials studying Tinnitus
18 Patients Enrolled for Tinnitus
Sven Vanneste, Prof.Principal InvestigatorTrinnitus College Dublin
~210 spots leftby Apr 2025